78 results
Page 4 of 4
8-K
EX-99.1
s98sb4aykpmf
7 Nov 19
Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
4:53pm
8-K
EX-99.1
bqxk1aj1
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
1w25vr 0o
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
EX-99.1
alxifzo70ud z5
15 Aug 19
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
8:09am
8-K
EX-99.1
6pxhdb2zxrdh2lfi45
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
215k7j2
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-99.1
9mtuu6ye
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
u8j4frg4si84dm1ua
2 Aug 19
Prospectus supplement for primary offering
4:28pm
8-K
m8msrny 0gco
29 Jul 19
Entry into a Material Definitive Agreement
4:05pm
S-3
qcmsux77ct hn26vaui5
21 Jun 19
Shelf registration
5:29pm
8-K
EX-10.2
yr2cv9n7zah7a kwg3
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K12B
EX-14.1
rse433evf6
14 Jun 19
Notification of registration of securities
5:10pm
424B3
q9ghuv hw
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
wip639co8c f5
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
2bpyi
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm